"DYRONIB" belongs to Tyrosine Kinase Inhibitor therapy of Oncology Division and it is available in 3 forms : Dasatinib 20Mg Tablet, Dasatinib 50Mg Tablet and Dasatinib 70Mg Tablet.
Copyright © 2021 All Rights Reserved by Hetero Healthcare Limited.